Clinical Trials Directory

Trials / Completed

CompletedNCT04312373

Efficacity of a Rigid Ankle Foot Orthosis for Persons With Ankle Osteoarthritis

Status
Completed
Phase
Study type
Observational
Enrollment
3 (actual)
Sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ankle osteoarthritis (AOA) is a typical long-term complication of an ankle injury. Pain during walking is the main symptom that limits walking distance. Non-surgical treatments could be used to decrease pain. The gold standard treatment for end-stage OA is definitive surgical ankle arthrodesis. The purpose of this study was to assess the effectiveness of a rigid ankle-foot orthosis (R-AFO) for walking pain in a population suffering from AOA.

Detailed description

This study used the SCED introduction/withdrawal methodology to assess the efficacy of R-AFO on pain and walking distance in the 2-minute walk test (2MWT). Each patient is his or her own comparator. During phase A, considered as the baseline, the patient performs the 2MWT without R-AFO. During phases B, considered as the introduction phases, the patient performs the tests with R-AFO. These tests are performed repeatedly and at regular intervals. The time of transition between phases has been randomized to have a minimum of 3 trials per phase. At the end of each test, an visual analogue scale for the pain and the walking distance travelled during the 2MWT were recorded.

Conditions

Interventions

TypeNameDescription
OTHERAnkle Foot OrthosisAccording to the SCED methodology, patients were fitted with ankle foot orthosis intermittently, during 4 phases, in the following order : without orthosis (A1), with orthosis (B1), again without orthosis (A2) and again with orthosis (B2). All the phases were carried out over one day.

Timeline

Start date
2017-02-01
Primary completion
2017-11-01
Completion
2017-12-30
First posted
2020-03-18
Last updated
2020-03-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04312373. Inclusion in this directory is not an endorsement.